Mi-Young Kim

507 total citations
23 papers, 400 citations indexed

About

Mi-Young Kim is a scholar working on Oncology, Molecular Biology and Gastroenterology. According to data from OpenAlex, Mi-Young Kim has authored 23 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Gastroenterology. Recurrent topics in Mi-Young Kim's work include Gastrointestinal motility and disorders (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Cancer Cells and Metastasis (2 papers). Mi-Young Kim is often cited by papers focused on Gastrointestinal motility and disorders (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Cancer Cells and Metastasis (2 papers). Mi-Young Kim collaborates with scholars based in South Korea, United States and United Kingdom. Mi-Young Kim's co-authors include Sang‐Woon Choi, Ji-Young Cha, Ki Baik Hahm, Jin-Sik Bae, Sung Bum Cho, Dae‐Seong Myung, Ho‐Geun Yoon, Seung‐Soon Im, Young‐Eun Joo and Wan‐Sik Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Mi-Young Kim

22 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mi-Young Kim South Korea 12 166 93 70 65 53 23 400
Christina Kopp Germany 8 106 0.6× 63 0.7× 79 1.1× 72 1.1× 43 0.8× 12 368
M. Firdos Ziauddin United States 11 203 1.2× 104 1.1× 56 0.8× 50 0.8× 25 0.5× 18 612
Juliette Joubert‐Zakeyh France 12 148 0.9× 60 0.6× 75 1.1× 36 0.6× 85 1.6× 19 424
Huiqin Hou China 9 408 2.5× 123 1.3× 69 1.0× 70 1.1× 88 1.7× 9 572
Xiao-bin Cheng China 12 271 1.6× 113 1.2× 61 0.9× 62 1.0× 49 0.9× 27 494
Blake A. Jones United States 7 195 1.2× 107 1.2× 124 1.8× 29 0.4× 126 2.4× 10 521
Hong Seok Choi South Korea 11 156 0.9× 101 1.1× 74 1.1× 46 0.7× 62 1.2× 24 484
Hanqing Guo China 9 174 1.0× 47 0.5× 72 1.0× 96 1.5× 27 0.5× 17 320
Jiayin Yao China 12 126 0.8× 52 0.6× 107 1.5× 37 0.6× 128 2.4× 32 466
Hongyan Chen China 10 165 1.0× 101 1.1× 84 1.2× 69 1.1× 40 0.8× 22 364

Countries citing papers authored by Mi-Young Kim

Since Specialization
Citations

This map shows the geographic impact of Mi-Young Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi-Young Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi-Young Kim more than expected).

Fields of papers citing papers by Mi-Young Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi-Young Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi-Young Kim. The network helps show where Mi-Young Kim may publish in the future.

Co-authorship network of co-authors of Mi-Young Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Mi-Young Kim. A scholar is included among the top collaborators of Mi-Young Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi-Young Kim. Mi-Young Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Minji, Sun‐Kyoung Im, Mi-Young Kim, et al.. (2024). rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 12(3). e008001–e008001. 9 indexed citations
2.
Im, Sun‐Kyoung, Minji Lee, Mi-Young Kim, et al.. (2022). Abstract 4172: rhIL-7-hyFc (efineptakin alpha; NT-I7) enhances the anti-tumor response when combined with anti-TIGIT or anti-VEGF. Cancer Research. 82(12_Supplement). 4172–4172. 1 indexed citations
3.
Kim, Mi-Young & Sang‐Woon Choi. (2021). Dietary modulation of gut microbiota for the relief of irritable bowel syndrome. Nutrition Research and Practice. 15(4). 411–411. 23 indexed citations
4.
Kim, Mi-Young, Jeong Ho Seok, Kyung‐Yong Kim, et al.. (2021). A Novel Therapeutic Anti-ErbB3, ISU104 Exhibits Potent Antitumorigenic Activity by Inhibiting Ligand Binding and ErbB3 Heterodimerization. Molecular Cancer Therapeutics. 20(6). 1142–1152. 11 indexed citations
5.
Kim, Mi-Young & Sang‐Woon Choi. (2020). Can Walnut Serve as a Magic Bullet for the Management of Non-Alcoholic Fatty Liver Disease?. Applied Sciences. 11(1). 218–218. 2 indexed citations
6.
Kim, Mi-Young, Annie J. Kruger, Ju‐Yeon Jeong, et al.. (2019). Combination Therapy with a PI3K/mTOR Dual Inhibitor and Chloroquine Enhances Synergistic Apoptotic Cell Death in Epstein–Barr Virus-Infected Gastric Cancer Cells. Molecules and Cells. 42(6). 448–459. 30 indexed citations
7.
Kim, Kwangsoo, et al.. (2018). ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes. Biochemical and Biophysical Research Communications. 498(3). 509–515. 18 indexed citations
8.
Kim, Mi-Young, et al.. (2017). study on Expanding the concept of Nonsul as a Lifelong literacy -focused on attributes of evaluating and extending tool for core competency-. 91–113.
9.
Han, Young‐Min, et al.. (2016). Genetic ablation or pharmacologic inhibition of autophagy mitigated NSAID-associated gastric damages. Journal of Molecular Medicine. 95(4). 405–416. 10 indexed citations
10.
11.
Lee, Eun Kyung, Bongkum Choi, Mi-Young Kim, et al.. (2015). Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice. Proceedings of the National Academy of Sciences. 112(42). 13081–13086. 17 indexed citations
12.
Lee, Wan‐Sik, Nuri Kim, Youngran Park, et al.. (2015). Myeloid cell leukemia-1 promotes epithelial-mesenchymal transition of human gastric cancer cells. Oncology Reports. 34(2). 1011–1016. 16 indexed citations
13.
Lee, Wan‐Sik, Young‐Lan Park, Nuri Kim, et al.. (2015). Myeloid cell leukemia-1 regulates the cell growth and predicts prognosis in gastric cancer. International Journal of Oncology. 46(5). 2154–1262. 27 indexed citations
14.
Kim, Hanna, et al.. (2015). Anti-inflammatory Effects of Sanguisorbae Radix on Contact Dermatitis Induced by Dinitrofluorobenzene in Mice. Chinese Journal of Integrative Medicine. 26(9). 688–693. 11 indexed citations
15.
Kim, Mi-Young & Hyojung Park. (2011). The Process of Symptom Control in Korean Women With Irritable Bowel Syndrome. Gastroenterology Nursing. 34(6). 424–432. 4 indexed citations
16.
Park, Sok, Mi-Young Kim, Soo‐Hwan Lee, et al.. (2009). Methanolic extract of onion (Allium cepa) attenuates ischemia/hypoxia-induced apoptosis in cardiomyocytes via antioxidant effect. European Journal of Nutrition. 48(4). 235–242. 42 indexed citations
17.
18.
Jung, Dukyoo, Hyojung Park, & Mi-Young Kim. (2008). A Study of Irritable Bowel Syndrome, Self-esteem, Depression, and Physical Health in Female University Students. Korean journal of women health nursing/Yeoseong geon'gang ganho hag'hoeji/Yeoseong geon-gang ganho hakoeji. 14(4). 306–306. 3 indexed citations
19.
Kim, Sung Eun, Mi-Young Kim, Do-Geun Kim, et al.. (2008). Determination of Fecal Shedding Rates and Genotypes of Swine Hepatitis E Virus (HEV) in Korea. Journal of Veterinary Medical Science. 70(12). 1367–1371. 16 indexed citations
20.
Kim, Mi-Young, et al.. (2004). A Case of Paronychia, Acneiform Eruption and Dry Skin Induced by Iressa$^{(R)}$. Linchuang pifuke zazhi. 42(5). 665–668. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Kopp Breakdown of academic impact, for papers by M. Firdos Ziauddin Breakdown of academic impact, for papers by Juliette Joubert‐Zakeyh Breakdown of academic impact, for papers by Huiqin Hou Breakdown of academic impact, for papers by Xiao-bin Cheng Breakdown of academic impact, for papers by Blake A. Jones Breakdown of academic impact, for papers by Hong Seok Choi Breakdown of academic impact, for papers by Hanqing Guo Breakdown of academic impact, for papers by Jiayin Yao Breakdown of academic impact, for papers by Hongyan Chen
Rankless by CCL
2026